Giotrif 20 mg
Giotrif 20 mg is a medicine authorised by Swissmedic under authorisation number 63042. The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 17 January 2014 and the authorisation is valid without a time limit. ATC code L01EB03 places the medicine in the group Antineoplastic agents.
| Authorisation number | 63042 |
|---|---|
| Name | Giotrif 20 mg |
| Full name | Giotrif 20 mg, Filmtabletten |
| Authorisation holder | Boehringer Ingelheim (Schweiz) GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01EB03 |
| First authorisation | 17 January 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Giotrif 20 mg, Filmtabletten | A | 17 January 2014 |
| 2 | Giotrif 30 mg, Filmtabletten | A | 17 January 2014 |
| 3 | Giotrif 40 mg, Filmtabletten | A | 17 January 2014 |
| 5 | Giotrif 50 mg, Filmtabletten | A | 27 September 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | L01EB03 | 07.16.1. | A |
| 2 | 28 | Tablette(n) | L01EB03 | 07.16.1. | A |
| 3 | 28 | Tablette(n) | L01EB03 | 07.16.1. | A |
| 4 | 28 | Tablette(n) | L01EB03 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Giotrif 20 mg authorised in Switzerland?
Yes. Giotrif 20 mg is authorised by Swissmedic under authorisation number 63042, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Giotrif 20 mg have?
Giotrif 20 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Giotrif 20 mg?
The authorisation holder is Boehringer Ingelheim (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.